AI in Drug Discovery Conference

this year’s event will feature topics including applications of AI/ML within target identification and computational drug design, the impact of generative AI on ways of working and clinical updates from the first AI-designed drug candidates.

tHE two-day agenda offers peer-to-peer networking with industry experts from an extensive selection of big pharma and breakthrough biotech’s in the field, including directors and heads of informatics, data & AI, molecular design, and computational chemistry.